Chapters

Transcript

Video

What did the investigators of the CAHtalyst pediatric trial observe in the way of weight loss in children and adolescents? Was this a pre-specified secondary end point?

What did the investigators of the CAHtalyst pediatric trial observe in the way of weight loss in children and adolescents? Was this a pre-specified secondary end point?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Richard Auchus, MD, PhD

Richard Auchus, MD, PhD

Professor of Pharmacology and Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan School of Medicine
Ann Arbor, Michigan